Joffe, S., Mamtani, R., Parikh, R. B., Lynch, H. F., Ferrell, W. J., Kurian, M., . . . Hubbard, R. (2025, May). Specificity of Food and Drug Administration postmarketing requirements and associations with timely submissions and regulatory decisions for oncology accelerated approvals, 2011–2023: A cross-sectional analysis. BMJ Oncology.
Chicago Style (17th ed.) CitationJoffe, Steven, Ronac Mamtani, Ravi B. Parikh, Holly Fernandez Lynch, William J. Ferrell, Martin Kurian, Ernesto Ulloa Perez, and Rebecca Hubbard. "Specificity of Food and Drug Administration Postmarketing Requirements and Associations with Timely Submissions and Regulatory Decisions for Oncology Accelerated Approvals, 2011–2023: A Cross-sectional Analysis." BMJ Oncology May. 2025.
MLA (9th ed.) CitationJoffe, Steven, et al. "Specificity of Food and Drug Administration Postmarketing Requirements and Associations with Timely Submissions and Regulatory Decisions for Oncology Accelerated Approvals, 2011–2023: A Cross-sectional Analysis." BMJ Oncology, May. 2025.
